Breaking News in Health: Vaccine Battles, Drug Developments, and Global Health Concerns

Recent health developments include Pfizer and BioNTech's win against CureVac's UK COVID vaccine patents, declining RSV vaccine sales, a single Mpox case in Uganda, Alzheimer’s drug development issues, and a push to remove all US lead pipes within a decade. These stories highlight ongoing challenges in the health sector.

In a victory for pharmaceutical giants Pfizer and BioNTech, London's High Court invalidated two CureVac patents related to COVID-19 mRNA technology. This legal win clears the way for Pfizer and BioNTech to continue dominating the COVID vaccine market without patent encumbrances.

Meanwhile, the demand for RSV vaccines from GSK and Pfizer has significantly dropped in the United States following a change in the targeted age group, leading to fewer people receiving the shot this season. Market observations indicate a steep decline, with sales figures aligning with projections made by healthcare analysts.

Beyond vaccines, the Biden administration has finalized a rule mandating the replacement of all lead pipes in US water systems within a decade, a move aimed at addressing long-standing environmental and health disparities across the nation.

(With inputs from agencies.)